Period Ending | Mar 31, 2012 | Dec 31, 2011 | Sep 30, 2011 | Jun 30, 2011 |
---|
Total Revenue
|
745,500
|
619,600
|
874,200
|
868,400
| Cost of Revenue |
-
|
-
|
-
|
-
| |
Gross Profit
|
745,500
|
619,600
|
874,200
|
868,400
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 255,700 | 279,900 | 236,700 | 239,100 |
|
Non Recurring | 24,300 | 63,400 | 22,400 | 29,100 |
|
Others | 67,700 | 66,200 | 65,400 | 64,700 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | |
Operating Income or Loss
|
451,200
|
390,400
|
572,100
|
534,500
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (17,800) | (20,700) | (26,200) | (25,200) |
|
Earnings Before Interest And Taxes | 462,500 | 398,800 | 574,900 | 538,000 |
|
Interest Expense | 29,100 | 29,100 | 29,000 | 28,700 |
|
Income Before Tax | 433,400 | 369,700 | 545,900 | 509,300 |
|
Income Tax Expense | 167,100 | (377,000) | 230,900 | 213,700 |
|
Minority Interest | 300 | (800) | 1,100 | (1,900) |
|
|
|
Net Income From Continuing Ops | 265,800 | 744,700 | 315,200 | 292,600 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
266,600
|
745,900
|
316,100
|
293,700
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
266,600
|
745,900
|
316,100
|
293,700
|
|